Conservative treatment of rectosigmoid endometriosis: A prospective study

Anne Gisselmann Egekvist, Edvard Marinovskij, Axel Forman, Ulrik Schiøler Kesmodel, Ole Graumann, Mikkel Seyer‐Hansen
Acta obstetricia et gynecologica Scandinavica · 2019 · vol. 98(9) , pp. 1139–1147 · doi:10.1111/aogs.13619 · PMID:30970147 · W2940298810
article OA: bronze CC0 ⤵ 14 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

This study followed 80 women with rectosigmoid endometriosis treated conservatively and found no association between nodule size and symptom changes, with quality of life remaining stable.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

INTRODUCTION: Deep infiltrating endometriosis is a common cause of pelvic pain. However, some patients have limited problems that may be controlled by medical treatment, so avoiding the potentially severe complications of major surgery. This approach requires detailed knowledge on quality of life and clinical symptoms over time. The aim of the study was to monitor these parameters in patients with rectosigmoid endometriosis treated with oral contraceptives, oral gestagens, and/or the levonorgestrel-releasing intrauterine device. Moreover, nodule size measurements performed with transvaginal sonography were correlated to severity of symptoms. MATERIAL AND METHODS: Conservatively treated patients on oral contraceptives, oral gestagens, or the levonorgestrel-releasing intrauterine device underwent transvaginal sonography and answered a self-administered questionnaire regarding clinical symptoms and quality of life (Short Form 36 and Endometriosis Health Profile 30) at baseline, and 6 and 12 months later. RESULTS: Eighty women completed the follow up. Scores of quality of life were comparable to normative data for Danish women of similar age and did not change with time. No association between change in size of the rectosigmoid nodule and change in symptoms was seen. CONCLUSIONS: This study supports that simple treatment with oral contraceptives, oral gestagens, or the levonorgestrel-releasing intrauterine device represents a viable therapeutic approach to rectosigmoid Deep infiltrating endometriosis, provided that proper selection of patients in need of surgery exists.

My notes (saved in your browser only)

Outcome instruments

EHP-30

Condition tags

mesh:D004715mesh:D017699endometriosisdie_deep_infiltrating

MeSH descriptors

Conservative Treatment Contraceptives, Oral Endometriosis Intrauterine Devices, Medicated Levonorgestrel Progestins Rectal Diseases Sigmoid Diseases Administration, Oral Adult Contraceptives, Oral Denmark Endometriosis Endometriosis Female Humans Levonorgestrel Pelvic Pain Pelvic Pain Progestins

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (30)

Cited by (14)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:22:54.901233+00:00
License: CC0 · commercial use OK